Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients

Yasuhiro Sakurauchi, Yoshihiro Matsumoto, Toru Shinzato, Ichiro Takai, Yutaka Nakamura, Motoyoshi Sato, Shigeru Nakai, Masamiki Miwa, Hiroyuki Morita, Toshihiko Miwa, Izumi Amano, Kenji Maeda

研究成果: ジャーナルへの寄稿学術論文査読

59 被引用数 (Scopus)


Various muscle symptoms are well recognized among patients on maintenance hemodialysis. Carnitine deficiency may be an important factor of dialysis-associated muscle symptoms, whereas high-dose L-carnitine supplementation may result in unphysiologically high plasma levels of carnitine and carnitine esters. We studied the effect of low-dose L-carnitine treatment (500 mg/d) on muscle symptoms, plasma carnitine fractions, and lipid profiles in 30 periodically dialyzed patients with muscular weakness, fatigue, or cramps/aches. After 12 weeks of L-carnitine treatment, about two- thirds of patients had at least some improvement in muscular symptoms, whereas carnitine fractions were normal or slightly above normal ranges, but lipid profiles showed no demonstrable changes. This study also showed the correlation between plasma-free carnitine deficiency and months on dialysis. These results suggest that prolonged low-dose L-carnitine treatment can improve dialysis-associated muscle symptoms by restoring carnitine tissue levels and washing out acyl moieties.

ジャーナルAmerican Journal of Kidney Diseases
出版ステータス出版済み - 08-1998

All Science Journal Classification (ASJC) codes

  • 腎臓病学


「Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。